Mont-Saint-Guibert, Belgium – September 2, 2024 10:05pm CET / 4:05PM ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the ...

Mont-Saint-Guibert, Belgium – October 6, 2025 7:00 CET / 1:00 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), a medical technology company that develops breakthrough treatment alternatives for ...

Nyxoah SA (NASDAQ:NYXH), a medical technology company specializing in the treatment of obstructive sleep apnea (OSA), is navigating a critical juncture as it prepares for a potential U.S. market entry ...

Nyxoah Sa ((BE:NYXH)) has held its Q3 earnings call. Read on for the main highlights of the call. Nyxoah’s recent earnings call for the third quarter of 2025 painted a picture of optimism amidst ...

MediaTek has come a long way since powering some of the weakest phones of the mid-2010s. The company’s chips are powering some of the most powerful phones and tablets on the market. Well, it’s taking ...

NEW DELHI: Taiwanese fabless chipmaker MediaTek Wednesday launched the Genio platform for Artificial intelligence of things (AIoT) devices, and alongside, unveiled the Genio 1200 chip. MediaTek said ...

For the third quarter ending September 30, 2025, research and development (“R&D”) expenses were €12.9 million, versus €7.9 million for the third quarter ending September 30, 2024. The increase in ...

LivaNova is poised to become Inspire Medical's first competitor in the United States with a fully implantable neurostimulation device for obstructive sleep apnea. London, England-based LivaNova ...

FDA regulatory submission for the Company’s Genio® device is complete, U.S. approval on track for the end of 2024 U.S. commercial launch, expected at the beginning of 2025, fully funded with over €85 ...